A newly identified antibody capable of neutralizing the inhalation anthrax toxin in rabbits and monkeys may offer an alternative method of preventing and treating infection in humans say US researchers. Their findings appear in the October 2006 issue of the journal Infection and Immunity.
One year after the Unite for Children. Unite against AIDS campaign, Guinea-Bissau, today launched a pediatric treatment effort against AIDS to ensure that the needs of infected and affected children are met.
The airplane leased by the Centers for Disease Control and Prevention (CDC) during public health emergencies saves lives – at a cost of one cent to each American each year. The plane plays a critical role in CDC’s ability to keep our nation safe and prepared.
All parties with an interest in the upcoming Intergovernmental Working Group on Public Health, Innovation and Intellectual Property are invited to present their views to web-based public hearings organized by the World Health Organization (WHO).
A significant and largely untapped global market exists for more effective and affordable tests to diagnose tuberculosis in low and middle income countries, where most TB cases today occur.
World Health Organization (WHO) and a group of more than 25 partner organizations unveiled a new strategy to fight some of the most neglected tropical diseases that destroy the lives and health of poor people.
What’s the best treatment for a cold? Some say rest and lots of liquids, others say to feed a cold and starve a fever. But what if a person has a cold with a fever? Does medication help?
Results from the SAINT II (Stroke Acute Ischemic NXY-059 Treatment) trial, announced today by AstraZeneca, showed that the investigational drug NXY-059 did not meet its primary outcome of a statistically significant reduction in stroke-related disability, as assessed by the modified Rankin Scale (mRS) (p=0.33, odds ratio 0.94) compared to placebo.
Point-of-use water treatment and improved water storage reduced the incidence of diarrhea by 90 percent when compared to improved water storage alone in camps for the internally displaced in Liberia, according to a study by researchers at the Johns Hopkins Bloomberg School of Public Health. In camp settings during emergencies, diarrheal diseases have accounted for more than 40 percent of all deaths, and a majority of deaths of small children. The study evaluated Procter & Gamble’s (NYSE: PG) PUR(R) Purifier of Water and is the first to test the effectiveness of PUR under emergency conditions. It is published in the October 2006 edition of Tropical Medicine and International Health.
IDM Pharma (NASDAQ:IDMI) announced today that the company has submitted an electronic New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for Junovan(TM) (mifamurtide for injection), requesting approval for its use in the treatment of newly diagnosed resectable high grade osteosarcoma patients following surgical resection in combination with multiple agent chemotherapy.